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LP-BM5 murine leukemia virus-infected C57BL/6 mice develop profound immunodeficiency and B-cell
lymphomas. The LP-BM5 complex contains a mixture of defective (BM5def) and replication-competent helper
viruses among which BM5def is the primary causative agent of disease. The BM5def primary open reading
frame (ORF1) encodes the single gag precursor protein (Pr60gag). Our lab has recently demonstrated that a
novel immunodominant cytotoxic-T-lymphocyte (CTL) epitope (SYNTGRFPPL) is expressed from a ⴙ1nucleotide translational open reading frame of BM5def during the course of normal retrovirus expression. The
SYNTGRFPPL CTL epitope may be generated from either of two initiation methionines present, ORF2a or
ORF2b, located downstream of the ORF1 initiation site. This study investigates the role(s) of the alternative
ORF2-derived gag protein(s) of BM5def in viral pathogenesis. We have examined the disease-inducing capabilities of mutant viruses in which the translational potential of either the initiating ORF2a or ORF2b AUG
has been disrupted. Although these mutated viruses are capable of wild-type ORF1 expression, they are unable
to induce disease. Our data strongly suggest the existence of a novel ORF2 product(s) that is required for
LP-BM5-induced pathogenesis and have potentially broad implications for other retroviral diseases.
BM5def ORF1-encoded Pr60gag protein exclusively. The essential role of ORF1 in pathogenesis has been established by
generating a myristylation-negative (Myr⫺) Pr60gag mutant of
BM5def (Du5H clone) (12). Similar to other myristylated proteins, Pr60gag on myristylation attaches to the inner leaflet of
the plasma membrane. Following this, myristylated Pr60gag
may interact with other membrane-bound molecules leading to
disease. The Myr⫺ Pr60gag mutant BM5def is unable to induce
either the expansion of target B cells or the splenomegaly
characteristic of MAIDS, demonstrating that an unaltered
Pr60gag ORF1 is necessary for viral pathogenesis (12). Other
groups have also established the crucial roles of ORF1 coding
regions of the Pr60gag gene in pathogenesis. By examining the
disease-inducing potential of MuLV-rescued BM5def carrying
truncated gag, it has been proposed that the MA (p15)- and
p12-encoding regions of BM5def gag are sufficient for pathogenicity (24). Also, substitution of the p15 and p12 sequences
of BM5def virus with BM5eco-specific sequences eliminates its
ability to induce MAIDS (17). Furthermore, by comparing
chimeric viruses with mutated p12 regions, the unique nucleotide sequence in the BM5def p12gag region, not homologous
to BM5eco, appears crucial for MAIDS development (16, 17).
Collectively, these observations (12, 16, 17, 24) have been
taken as confirmation of the essential role of ORF1 in pathogenesis.
However, these studies have concentrated on modifying only
nucleotide sequences and considering their resultant changes
in the ORF1-derived Pr60gag polypeptide. The potential that
alternative open reading frames (and consequently proteins
encoded by them) are embedded within the BM5def gag gene
and may play an important role in pathogenesis of BM5def has
not yet been studied. In addition to studying viral pathogenesis,
our lab has focused on protective immune responses in

Genetically susceptible C57BL/6 (B6) mice infected with the
LP-BM5 retroviral isolate (18) develop immunodeficiency similar to AIDS. This disease is called murine AIDS (MAIDS),
stages of which are characterized by splenomegaly, lymphadenopathy, hypergammaglobulinemia, profound immunodeficiency, and B-cell lymphomas in the context of retroviral-induced immunodeficiency, generally similar to AIDS-related
non-Hodgkin’s lymphomas. Among the three classes of murine
leukemia viruses (MuLV) in the LP-BM5 isolate, the BM5eco
(and possibly recombinant mink cell focus-forming virus)
MuLV function as helper viruses for the replication-defective
BM5def, which is the primary etiological agent causing disease
(1, 4, 13, 18). Two molecular clones of the defective genome,
Du5H and DEF27, have been characterized from different
isolates, with both revealing large common regions of pol and
env that have been deleted (1, 5). The BM5def primary open
reading frame (ORF1) encodes the single gag precursor protein (Pr60gag). The BM5def gag sequences encoding the core
proteins MA (p15), CA (p30), and NC (p10) have 80 to 90%
homology to the analogous sequences in the Pr65gag of other
ecotropic MuLV. However, within a 25-amino acid (aa) segment at the carboxy-terminal end of p15 and another 25-aa
region in p12, BM5def displays a distinctively high diversity
from the nonpathogenic BM5eco and other typical replicationcompetent ecotropic MuLV (1, 5) (Fig. 1A).
All of the work done to understand LP-BM5-induced pathogenesis, including yeast two-hybrid screening for host proteins
that bind BM5def gag protein, has focused conceptually on the
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FIG. 1. (A) Differences in alternative ORF coding potentials of BM5eco and BM5def. (B) Generation of BM5defORF2aAUGmut and
BM5defORF2bAUGmut viruses.

MAIDS-resistant BALB/c mice (20, 22, 26). We and others
have shown that resistance in H-2a and H-2d mouse strains is
primarily dependent on CD8⫹ T cells (19, 20, 22, 23, 26, 27).
Specifically, we have demonstrated that an H-2Kd-restricted
immunodominant cytotoxic-T-lymphocyte (CTL) epitope is
nontraditionally expressed from an alternative translational
gag ORF during the course of normal in vivo and in vitro
LP-BM5 retrovirus expression (22). Thus, we have shown that
in MAIDS-resistant BALB/cByJ, C57BL/KsJ, and (BALB/c ⫻
C57BL/6)F1 mice, CTLs raised against BM5eco or BM5def gag
protein are directed against the conserved p30-encoding region, but in fact are specific for a novel epitope (SYNTG
RFPPL) generated from a second, ⫹1-nucleotide (nt) register

defined as ORF2 (20, 22). Our lab also demonstrated that, in
the context of the extended minigene constructs used for minimal epitope mapping, generation of SYNTGRFPPL depends
on a naturally occurring ORF2 Met initiation codon (22).
Hence, it seems likely that SYNTGRFPPL expression in the
context of full-length BM5def gag is also the result of conventional AUG-directed translation. Thus, the SYNTGRFPPL
epitope may be generated from either one of two potential
initiation codons in BM5def gag ORF2, i.e., starting at 157
(ORF2a AUG) or 646 (ORF2b AUG) nt, respectively, downstream of the ORF1 AUG. According to the Kozak consensus
sequence (15), ORF2a is in a strong, and ORF2b is in a very
strong, initiation codon context (21, 22). This extended alter-
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native gag ORF is unique for retroviral systems, especially
when comparing BM5def to other ecotropic MuLV such as
AKR623, Friend, and Moloney. Furthermore, given the usual
frequent random occurrences of stop codons in the ⫹1- and
⫹2-nt registers, the extended BM5def ORF2 predicted
maximum protein is unusually long at 193 aa (Fig. 1A).
Based on these observations, the present study examines the
role(s), if any, of the alternative ORF2-derived gag protein(s)
of BM5def in viral pathogenesis. Significantly, as the pathogenic BM5def viral component is replication incompetent, the
putative ORF2 protein(s) it encodes cannot be crucial to replication. Rather, we hypothesize that in addition to the primary
ORF1-encoded Pr60gag, BM5def ORF2 translation proceeding
from the ORF2a and/or ORF2b AUG(s) gives rise to protein(s) of 193 or 30 aa in length (maximally), and one or both
of these ORF2 products are required for LP-BM5 viral pathogenesis per se.
MATERIALS AND METHODS
Viruses. LP-BM5 was prepared in our laboratory as previously described (11).
The molecular clone for the wild-type (wt) BM5def, p127/A1, generously provided by Sisir Chattopadhyay, was used to generate the BM5defORF2aAUGmut
or BM5defORF2bAUGmut mutant viruses. A QuickChange kit from Stratagene
was used for site-directed mutagenesis. The primers used to generate the
BM5defORF2aAUGmut mutant were 5⬘ CCACTAGACGGTACTTTTAATTT
AGAC and 3⬘ AATGTCTAAATTAAAAGTACCGTCTAG. To generate the
BM5defORF2bAUGmut mutant, the primers used were 5⬘ GTATTGTAACTGA
CCGTTACCCCCCAAACG and 3⬘ CGTTTGGGGGGTAACGGTCAGTTAC
AATAC.
Mice. Seven-week-old male C57BL/6NCr mice were purchased from the National Cancer Institute, housed at the Dartmouth Medical School animal facility,
and infected intraperitoneally with 2.5 ⫻ 104 PFU of LP-BM5 or BM5ecorescued wt BM5def or BM5defORF2aAUGmut or BM5defORF2bAUGmut viruses
at 8 to 10 weeks of age.
Activational and immunosuppressive parameters of MAIDS pathogenesis.
Enzyme-linked immunosorbent assay determinations of serum immunoglobulin
(Ig), splenomegaly measurements, allo-CTL and 51Cr release assays, and proliferation assays in response to mitogen were carried out as previously described
(11).
BM5def gag GFP-tagged fusion proteins. We used the enhanced green fluorescent protein (EGFP) to generate the wt or mutant ORF1AUGEGFP or
ORF2AUGEGFP fusion proteins. The GFP fragment was subcloned out of the
pEGFP-N1 plasmid (BD Biosciences, Clontech) and in frame with the AUGs of
the BM5def ORF1, BM5def ORF2a, or BM5def ORF2b.
Viral load. By using a real-time SYBR-Green/iCycler iQ-based quantitative
assay that our lab has recently developed (7), quantitative reverse transcriptionPCR (qRT-PCR) assays were used to quantify BM5def and BM5eco gag RNA
levels. Primers used in this qRT-PCR assay were designed to specifically distinguish between BM5def gag and BM5eco gag and have been described previously
(7). It is important to note that primers for BM5eco gag were generated by using
unique BM5eco sequences found at base pairs 1188 and 1370 relative to the
BM5eco gag initiating ATG and these defining nucleotides specific to BM5eco
(and not to BM5def) were positioned at the 3⬘ end.

RESULTS AND DISCUSSION
Presence of alternative reading frames in BM5def and generation of BM5defORF2aAUGmut and BM5defORF2bAUGmut
mutant viruses. By using site-directed mutagenesis, we introduced a series of nucleotide changes in the BM5def molecular
clone, Def27, to disrupt the translational potential of either the
ORF2a or ORF2b AUG-defined reading frames. These mutants carrying disrupted ORF2a or ORF2b AUGs are referred
to as either BM5defORF2aAUGmut or BM5defORF2bAUGmut
viruses, respectively. The mutations in ORF2a or ORF2b were
carefully designed so as to alter neither the sequence integrity
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nor the preferred mammalian codon usage (8) of ORF1. The
BM5defORF2aAUGmut virus was generated by mutating the
most-5⬘ ORF2 start AUG (nt 157 to 159) to ACG and additionally introducing a stop codon at position 169 to 171 (Fig.
1A and B). The BM5defORF2bAUGmut virus was generated by
mutating the more-3⬘ ORF2 AUG (nt 646 to 648) to ACG, as
it was impossible to engineer an adjacent stop codon without
altering the amino acid coding sequence in ORF1 (Fig. 1B).
Viral stocks were produced by generating stable transfectants
of the wt BM5def (as a transfection control) or the mutated
viruses in SC-1eco cells that are chronically infected with the
helper BM5eco virus. BM5eco-rescued viral stocks, prior to
injection into B6 mice, were confirmed for the presence of
BM5eco and BM5def (wt or mutants) by RT-PCR and realtime qRT-PCR assays (7) (data not shown). In addition, the
mutations were verified by sequencing. Viral stocks were adjusted for delivery of an equivalent infectious titer of 2.5 ⫻ 104
PFU, as determined by the XC-plaque assay (25) (data not
shown). Additionally, viral genomic RNA was isolated from
the stocks and converted to cDNA, and viral RNA copy numbers were determined by qRT-PCR by using standard curves.
We determined that our standard infectious viral titer of 2.5 ⫻
104 PFU of LP-BM5 averaged approximately 1.3 million (⫾0.2
million) copies of BM5eco RNA and 1.93 million (⫾0.05 million) copies of BM5def RNA. Similarly, the number of viral
genomes per 2.5 ⫻ 104 PFU for the BM5eco-rescued viral
preparations were as follows: (i) wt BM5def (transfection control), 1.14 million (⫾0.14 million) copies of BM5eco RNA and
1.97 million (⫾0.04 million) copies of BM5def RNA; (ii)
BM5defORF2aAUGmut, 1.12 million (⫾0.2 million) copies of
BM5eco RNA and 1.82 million (⫾0.04 million) copies of
BM5def RNA; (iii) BM5defORF2bAUGmut, 1.32 million (⫾0.2
million) copies of BM5eco RNA and 1.9 million (⫾0.03 million) copies of BM5def RNA.
Ability of BM5def ORF2a and ORF2b AUGs to initiate
translation of GFP fusion proteins. In order to determine the
translational potential of the alternative ORF2a and ORF2b
AUGs, we first generated BM5defORF1AUGEGFP (as a positive control) and BM5defORF2aAUGEGFP and BM5def
ORF2bAUGEGFP tagged viruses. These constructs allow for
the expression of the ORF1 or ORF2a or ORF2b AUG-defined reading frames as fusions to the N terminus of EGFP
(Fig. 2A). Thus, the EGFP gene, including its endogenous stop
codon, was cloned at the C terminus of, and in the same
reading frame as, either the ORF1, ORF2a, or ORF2b AUGs,
with no intervening in-frame stop codons. For the BM5def
ORF2aAUGEGFP construct, EGFP was cloned 5⬘ of the
ORF2b initiation AUG to ensure that all EGFP expression
would necessarily emanate only from the ORF2a initiation
AUG. Stable transfectants of the EGFP-tagged BM5def viruses were generated in SC-1eco cells and analyzed for EGFP
fusion protein expression by fluorescence-activated cell sorting
(FACS). GFP expression was detected in cells carrying
BM5defORF1AUGEGFP as expected and also by BM5def
ORF2aAUGEGFP- or BM5defORF2bAUGEGFP-transfected
cells (Fig. 2A). Importantly, BM5defORF2a/2b AUG-directed
EGFP expression was detected at somewhat lower (24% lower
total mean fluorescence intensity) but still very substantial levels compared to the conventional BM5def ORF1-directed levels. Additionally, to ascertain how much EGFP expression in
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FIG. 2. (A) BM5def gag ORF1AUG- versus ORF2AUG- directed EGFP expression. (B) BM5def ORF2bAUGEGFP versus
BM5defORF2aAUGmut;ORF2bAUGEGFP expression. (C) GFP expression in viruses carrying either the ORF2aAUGmut or ORF2bAUGmut mutations. In all three panels, the dark gray filled-in histograms are the negative controls of untransfected Sc-1eco cells, while the light gray filled-in
histograms represent Sc-1eco cells transfected with BM5defORF1AUGEGFP. The black solid line and dashed line represent the following:
(A) Sc-1eco cells transfected with BM5defORF2aAUGEGFP or BM5defORF2bAUGEGFP viruses, respectively; (B) Sc-1eco cells transfected with
BM5defORF2bAUGEGFP or BM5defORF2aAUGmut;ORF2bAUGEGFP viruses, respectively; (C) Sc-1eco cells transfected with BM5def
ORF2aAUGmutEGFP or BM5defORF2bAUGmutEGFP viruses, respectively. These data are representative of three independent experiments. FACS
analyses for cells in panels A and C and in Fig. 3 were carried out on the same day while that for panel B was done independently. Each histogram
depicts a stable transfectant population which is representative of at least two independently transfected populations that were tested for GFP
expression by FACS.

the BM5defORF2bAUGEGFP construct originated from the
ORF2b AUG specifically (and not as a read-through from the
upstream intact ORF2a AUG), we also generated a construct
wherein the ORF2a AUG was mutated and the EGFP gene
was cloned 5⬘ of and in the same reading frame as the ORF2b
(BM5defORF2aAUGmut;ORF2bAUGEGFP, Fig. 2B). SC-1eco
cells
transfected
with
this
BM5defORF2aAUGmut;
ORF2bAUGEGFP virus expressed considerable GFP (only
37% lower total mean fluorescence intensity than the
BM5defORF2bAUG carrying the unmutated ORF2a AUG),
confirming that the ORF2b initiation AUG was independently
capable of translating a fusion protein without any readthrough from the upstream intact ORF2a AUG (Fig. 2B).
To verify that the GFP was being translated from the initiation AUGs of ORF2a or ORF2b and that the introduced
mutations were effective in disrupting ORF2a or ORF2b
AUG-initiated translation, EGFP was similarly engineered
into the BM5defORF2aAUGmut and BM5defORF2bAUGmut viruses (Fig. 2C). To generate the BM5defORF2aAUGmutEGFP

virus, EGFP was cloned 5⬘ of the ORF2b initiation AUG.
Compared to the BM5defORF2aAUGEGFP, the total mean
fluorescence intensity of BM5defORF2aAUGmutEGFP was
consistently lowered in three independent experiments by
⬎99%; essentially this mutant did not appear to express detectable GFP (Fig. 2C). These data clearly show that the
ORF2a AUG is capable of initiating translation of a fusion
protein, and the introduced mutations inhibit ORF2a AUGinitiated translation. In contrast, mutation of the ORF2b initiation codon did not completely inhibit the EGFP signal (Fig.
2C), as predicted from the results in Fig. 2B. Rather, the
mutated BM5defORF2bAUGmutEGFP expressed substantial
GFP (only 30% lower total mean fluorescence intensity than
BM5defORF2bAUG), most probably due to the read-through
from the intact ORF2a AUG (also see below).
BM5def ORF1-encoded gag is expressed in the
BM5defORF2aAUGmut or BM5defORF2bAUGmut mutants. To
confirm that the mutations introduced in BM5def ORF2a or
ORF2b AUGs are in no way detrimental to the translation of
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FIG. 3. ORF1AUGEGFP expression in viruses carrying either the
ORF2aAUGmut or ORF2bAUGmut mutations. The dark gray filled-in
histogram is the negative controls of untransfected Sc-1eco cells while
the light gray filled-in histogram represents Sc-1eco cells transfected
with BM5defORF1AUGEGFP. The black solid line and dashed line
represent Sc-1eco cells transfected with BM5defORF1AUGEGFP
cloned into BM5defORF2aAUGmut or BM5defORF2bAUGmut viruses,
respectively. These data are representative of three independent experiments.

ORF1, which is required for viral pathogenesis, we also generated viruses with the ORF1AUGEGFP fusion construct in
both the BM5defORF2aAUGmut and BM5defORF2bAUGmut
viruses. The EGFP fragment was cloned in frame with the
initiating AUG, and at the C terminus, of ORF1 in both mutants (Fig. 3). The wt BM5def carrying the ORF1AUGEGFP
fusion protein defined above was used as a positive control in
analogous FACS experiments. ORF1AUGEGFP expression
was detected in the BM5defORF2aAUGmut or BM5def

J. VIROL.

ORF2bAUGmut viruses at levels indistinguishable from this positive control (Fig. 3). These data confirm that ORF1 AUGinitiated translation is not disrupted in the BM5def
ORF2aAUGmut or BM5defORF2bAUGmut mutants, thus allowing us to address the potential need for ORF2 translation for
pathogenesis under conditions of normal levels of required
ORF1 product.
Activational and immunosuppressive parameters of MAIDS
pathogenesis are not induced by the BM5defORF2aAUGmut or
BM5defORF2bAUGmut mutants. To assess the pathogenicity of
BM5def viruses mutated to inhibit translation from their alternative ORF2 AUGs, B6 mice were infected with rescued preparations carrying BM5eco virus and either the BM5def
ORF2aAUGmut or BM5defORF2bAUGmut mutant virus or with
positive (LP-BM5 and wt BM5def rescued with BM5eco) or
negative (phosphate-buffered saline) controls. Splenomegaly,
as a standard activational parameter characteristic of MAIDS
(10, 11), was determined 11 weeks postinfection (wpi) by
spleen weight (Fig. 4A). At 5, 9, and 11 wpi, serum IgG2a and
IgM levels were determined (11 wpi; Fig. 4B), as a measure of
the generalized hyper-Ig of MAIDS. Compared to the LPBM5 or wt BM5def rescued control-infected mice, B6 mice
infected with either the BM5defORF2aAUGmut (P ⬍ 0.001) or
BM5defORF2bAUGmut (P ⬍ 0.001) virus did not induce measurable splenomegaly or hypergammaglobulinemia. This pattern was replicated in three additional independent experiments.
In addition, a standard panel of immunosuppressive parameters was measured at termination 11 wpi: responses to mitogens by T (ConA) versus B (lipopolysaccharide) cells, as well
as the generation of alloantigen-specific (anti-H-2d) CTL activity. Again, in contrast to LP-BM5 or wt BM5def rescued
control-infected mice, B6 mice infected with the BM5eco-rescued BM5defORF2aAUGmut or BM5defORF2bAUGmut mutants did not develop disease, i.e., they had normal mitogen
responses (Fig. 4C; data representative of four independent
experiments, P ⬍ 0.001) and generation of CTL activity (Fig.
4D; data representative of three independent experiments).
These results were further confirmed by flow cytometric analyses for the characteristic spleen cell phenotypic changes that
are observed in uninfected versus LP-BM5-infected B6 mice
(9, 14). LP-BM5 or wt BM5def rescued control-infected mice
showed the expected expanded populations of CD19ⴙ CD23⫺
and CD4ⴙ Thy1.2⫺ spleen cells, but these changes were not
observed in mice infected with the BM5defORF2aAUGmut or
BM5defORF2bAUGmut mutant (data not shown).
Determination of BM5def and BM5eco gag RNA levels in
infected mice. On termination of each experiment, we verified
the presence of the appropriate control and experimental viruses in infected mice and quantified their expression by qRTPCR assays for BM5eco and BM5def (7). Although there was
no evidence of MAIDS induction by the BM5def
ORF2aAUGmut or BM5defORF2bAUGmut preps, mice infected
with these mutants expressed substantial levels of both
BM5eco and BM5def (Fig. 5). BM5def gag RNA was more
abundant than BM5eco gag RNA in spleen cells from both
control and viral mutant-infected mice. These data are similar
to what our lab has observed previously (7) as well as to
BM5def and BM5eco gag RNA levels determined in the viral
stocks that were generated in vitro and used for infecting mice
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FIG. 4. Susceptibility of BM5eco-rescued wt or mutant BM5def-infected B6 mice to MAIDS. (A) Spleen size (mg). (B) Serum IgM and IgG2a
response. (C) Spleen cell proliferation in response to T-cell mitogen (ConA, 2 g/ml) and B-cell mitogen (lipopolysaccharide, 10 g/ml).
(D) Allogeneic cytotoxic-T-lymphocyte responses of spleen cells at 11 wpi. E:T, effector-to-target ratio. Means and standard deviations represent
three mice per group and the data are representative of four independent experiments for panels A, B, and C and three independent experiments
for panel D. Statistical analyses were carried out on LP-BM5-infected mice and B6 mice infected with either BM5defORF2aAUGmut or
BM5defORF2bAUGmut (P ⬍ 0.001 by Student t test). PBS, phosphate-buffered saline.

in this study (data not shown). BM5eco gag and BM5def gag
RNA levels from mice infected with the BM5def
ORF2aAUGmut or BM5defORF2bAUGmut mutant viruses were
only about two- to threefold lower than the viral loads for wt
rescued control and LP-BM5-infected mice (Fig. 5). It seems

FIG. 5. Viral load for BM5eco gag and BM5def gag RNA quantified by qRT-PCR from spleen cells of infected mice at 11 wpi. These
qRT-PCR data are representative of RNA isolated from infected
spleens in four independent experiments.

very unlikely that this degree of difference in viral load would
be sufficient to account for the absence of disease induction
after infection by the mutated BM5def preparations. The
higher viral loads in the positive controls, in this case infection
with nonmutated viral preps, seem to simply reflect the fact
that in full-blown MAIDS the characteristic extensive lymphoproliferation is a major contributor to the spread of the virus,
in addition to multiple rounds of infection by free virions. This
concept that B6 background mouse strains resistant to MAIDS
pathogenesis still exhibit a substantial viral load indicative of
normal initial infection and early viral spread has been further
supported by both viral titration experiments and the study of
several MAIDS-resistant versus -susceptible B6 strains, with
either of the genes knocked out (CD154, CD40, CD80/86) or
as chimeric CD40 transgenics (9, 10, 11). As we have previously discussed in some detail (9), these comparisons across
mouse strains have shown that distinctly measurable disease
can be observed under conditions that result in a few-fold
lower BM5def viral load at termination of the experiment. In
addition, on termination of each experiment, by using RT-PCR
we isolated the BM5def viruses from spleen cells and sequenced them. Sequencing data confirmed the presence of
only the wt BM5def in the mice infected with the positive
control viral preps, versus only the appropriate mutant sequence in the mice infected with the experimental viruses. An
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inherent advantage of this system is that any reversion of the
mutated to the wt sequence would have resulted in a defective
virus that would have caused disease. These data clearly suggest that a virus different from what was initially injected into
the mice had not arisen to detectable levels as a result of
reversion during the 11-week course of infection.
In summary, based on (i) both activational and immunodeficiency parameters of MAIDS (Fig. 4), (ii) viral load data (Fig.
5), and (iii) sequence analysis of viruses isolated from mice 11
wpi, and ORF1/ORF2 expression data (Fig. 2 and 3), it is
evident that the viral mixes consisting of either wt BM5ecorescued ORF2aAUGmut or ORF2bAUGmut BM5def virus, each
with intact wt ORF1 expression capability, are essentially unable to induce disease. These data strongly suggest the existence of a novel ORF2 product(s) that is required for LP-BM5induced pathogenesis. The ORF2 product(s) may be initiated
from either the ORF2a or ORF2b AUG (Fig. 2), as disruption
of either one of their translational potentials leads to inhibition
of disease (Fig. 4). One interpretation of these findings is that
there is a requirement for both protein products of 193 and 30
aa, produced as separate entities from the ORF2a and ORF2b
AUGs, respectively. These proteins may be independently essential in targeting different specific host cellular proteins. Alternatively or in addition, the two alternative ORF2 translational products may function together to cause disease by
independently interacting with the same host cell protein target or combining to form a single ORF2a/ORF2b heterodimer.
As an option to two separate ORF2 protein products, it is
also possible that only a single protein initiating from the
ORF2a AUG is required. Thus, the data from the
BM5defORF2bAUGmutEGFP mutant virus (Fig. 2C) show
that, despite disrupting the initiation AUG of ORF2b, GFP is
still expressed (albeit at a reduced level) as a fusion protein,
apparently from the unaltered ORF2a AUG which is in the
same ⫹1-nt reading frame as ORF2b (Fig. 2B). Importantly,
however, the BM5defORF2bAUGmut virus is unable to cause
disease. This finding could be explained based not on the
ORF2b AUG mutation as a block to translation initiation at
this site but rather on the basis of the introduction of a missense mutation at the ORF2b site in the ORF2a AUG-initiated maximal ORF2 protein. Thus, the presence of threonine
instead of methionine may be deleterious to the structure of
the extended protein produced from the ORF2a AUG.
The results presented in this paper support the existence of
an alternative translation initiation mechanism in BM5def for
the expression of an ORF2-encoded gag product(s) and its
requirement in LP-BM5-induced pathogenesis. These data
have obvious implications for pursuing the molecular mechanisms by which BM5def causes disease and studies are currently under way to identify the nature and function of the
necessary ORF2 product(s). Our data are interesting to compare to the results of other labs that have also studied atypically encoded CTL epitopes, including in human immunodeficiency virus (2, 3, 6, 28). In particular, and comparable to our
novel BM5def ORF2a and/or ORF2b AUG(s)-encoded 193 or
30 aa protein(s), a previously unobserved, conserved 87-residue protein encoded by influenza A virus has recently been
identified by first defining a CTL epitope encoded in an alternative translational ORF (6). This immunogenic influenza virus protein, PB1-F2, recognized by CD8⫹ T cells, is derived
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from a ⫹1 alternative reading frame and may play a critical
role in pathogenesis by inducing apoptosis in host immune
cells that respond to influenza virus infection (6). Our identification of an immunodominant CTL epitope novelly expressed from an alternative translational gag ORF (20, 22),
combined with our present data that the ORF2-encoded extended gag product(s) have a functional role in disease induction, raise the possibility that alternative reading frame-derived
proteins may also be crucial in other disease models.
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